FDA updates labeling for TOPIRAMATE
Labeling changes approved for GLENMARK PHARMS LTD. Active ingredient: TOPIRAMATE. Decision date: 12/04/2025
Labeling changes approved for GLENMARK PHARMS LTD. Active ingredient: TOPIRAMATE. Decision date: 12/04/2025
There are no comments here yet...